{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:11:06Z","timestamp":1761174666820,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":3619,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1111\/j.1469-0691.2004.01017.x","type":"journal-article","created":{"date-parts":[[2005,1,11]],"date-time":"2005-01-11T05:37:38Z","timestamp":1105421858000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Activity of the new quinolone WCK 771 against pneumococci"],"prefix":"10.1016","volume":"11","author":[{"given":"P.C.","family":"Appelbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Pankuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bozdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.V.","family":"Gupte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J. De","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.F.","family":"Khorakiwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl A","key":"10.1111\/j.1469-0691.2004.01017.x_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/43.suppl_1.31","article-title":"The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective","volume":"43","author":"Thomson","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1473-3099(02)00369-9","article-title":"Fluoroquinolone resistance among Gram-positive cocci","volume":"2","author":"Hooper","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: an overview","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/clinids\/15.1.119","article-title":"Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae","volume":"15","author":"Jacobs","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00013542-199504000-00001","article-title":"antibiotic resistance: a 10 year perspective","volume":"6","author":"Jacobs","year":"1995","journal-title":"Rev Med Microbiol"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3201\/eid0909.020620","article-title":"Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae","volume":"9","author":"Van Beneden","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib8","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1128\/AAC.36.10.2176","article-title":"Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States","volume":"36","author":"McDougal","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/clinids\/15.1.112","article-title":"Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis","volume":"15","author":"Munoz","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/321877","article-title":"Dissemination of antibiotic-resistant bacteria across geographic borders","volume":"33","author":"Okeke","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00006454-199206000-00002","article-title":"Management of penicillin-resistant pneumococcal infections","volume":"11","author":"Friedland","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib12","first-page":"3773","article-title":"Management of infections caused by antibiotic-resistant Streptococcus pneumoniae","volume":"331","author":"Friedland","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jac\/43.5.645","article-title":"Anti-pneumococal activity of gatifloxacin compared with other quinolone and non-quinolone agents","volume":"43","author":"Hoellman","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1128\/AAC.44.2.304-310.2000","article-title":"Antipneumococcal activities of gemifloxacin compared to those of nine other agents","volume":"44","author":"Davies","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/jac\/35.1.230","article-title":"Activity of CP 99,219 compared with DU-68859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and-resistant pneumococci","volume":"35","author":"Pankuch","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1128\/AAC.36.4.856","article-title":"Susceptibilities of penicillin-susceptible and susceptible strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, WIN 57273, ofloxacin, and ciprofloxacin","volume":"36","author":"Spangler","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/31.2.273","article-title":"Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829","volume":"31","author":"Spangler","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/AAC.40.2.362","article-title":"MIC and time-kill study of activities of DU-68859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci","volume":"40","author":"Visalli","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib19","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1128\/AAC.41.12.2786","article-title":"Antipneumococcal activity of BAY 12-8039a, new quinolone, compared with activities of three other quinolones and four oral \u03b2-lactams","volume":"41","author":"Visalli","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib20","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib22","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJM199911113412013","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae","volume":"341","author":"Li\u00f1ares","year":"1999","journal-title":"N Engl J Med"},{"year":"2003","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","key":"10.1111\/j.1469-0691.2004.01017.x_bib23"},{"year":"2004","series-title":"Performance standards for antimicrobial susceptibility testing, fourteenth informational supplement","author":"National Committee for Clinical Laboratory Standards","key":"10.1111\/j.1469-0691.2004.01017.x_bib24"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib25","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/AAC.42.8.2032","article-title":"Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae","volume":"42","author":"Brenwald","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/AAC.43.5.1177","article-title":"In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae","volume":"43","author":"Davies","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib27","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/AAC.44.10.2740-2746.2000","article-title":"In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae","volume":"44","author":"Nagai","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib28","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/AAC.38.9.2065","article-title":"Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology","volume":"38","author":"Pankuch","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3181\/00379727-57-14776","article-title":"Estimation of the ED50 and its error by means of logarithmic-probit graph paper","volume":"57","author":"Miller","year":"1994","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharm Exp Ther"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/AAC.43.2.329","article-title":"Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci","volume":"43","author":"Jorgensen","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/44.5.621","article-title":"Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin","volume":"44","author":"Pong","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-199958002-00003","article-title":"Mechanisms of fluoroquinolone resistance: an update 1994-1998","volume":"58","author":"Piddock","year":"1999","journal-title":"Drugs"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2004.01017.x_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/45.suppl_3.13","article-title":"In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA","volume":"45","author":"McCloskey","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2004.01017.x_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0924-8579(01)00343-0","article-title":"Comparative killing kinetics of the novel des-fluoro (6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams","volume":"18","author":"Gradelski","year":"2001","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14621893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14621893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:14:48Z","timestamp":1761117288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14621893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1198743X14621893"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2004.01017.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of the new quinolone WCK 771 against pneumococci","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1469-0691.2004.01017.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}